About Amyris
Amyris is a company based in Emeryville (United States) founded in 2003.. Amyris has raised $487.2 million across 61 funding rounds from investors including SAS, Kleiner Perkins and dsm-firmenich. The company has 747 employees as of December 31, 2022. Amyris has completed 8 acquisitions, including Beauty Labs, Costa Brazil and Draths Corporation. Amyris offers products and services including Sustainable Ingredients and Squalene. Amyris operates in a competitive market with competitors including Syngenta, AskBio, Ginkgo Bioworks, Twist Bioscience and Antheia, among others.
- Headquarter Emeryville, United States
- Employees 747 as on 31 Dec, 2022
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Amyris, Inc.
-
Annual Revenue
$269.85 M-21as on Dec 31, 2022
-
Net Profit
$-528.51 M-95as on Dec 31, 2022
-
EBITDA
$-568.98 M-220as on Dec 31, 2022
-
Total Equity Funding
$487.2 M (USD)
in 61 rounds
-
Latest Funding Round
-
Investors
SAS
& 18 more
-
Employee Count
747
as on Dec 31, 2022
-
Investments & Acquisitions
Beauty Labs
& 7 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Amyris
Amyris offers a comprehensive portfolio of products and services, including Sustainable Ingredients and Squalene. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Bioidentical molecules for skincare and vaccines via fermentation
Sustainable alternative for vaccine adjuvants and cosmetics
Unlock access to complete
Unlock access to complete
Software Development Team
42 people
Leadership Team
24 people
Product Management Team
17 people
Senior Team
12 people
Sales and Marketing
10 people
Human Resources and Administration
8 people
Data Analysis and Operations Team
7 people
Process Team
7 people
Unlock access to complete
Funding Insights of Amyris
Amyris has successfully raised a total of $487.2M across 61 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 61
- Last Round Last Round
- First Round First Round
- Investors Count 19
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec, 2022 | Amount | Post-IPO - Amyris | Valuation |
investors |
|
| Dec, 2020 | Amount | Post-IPO - Amyris | Valuation |
investors |
|
| Jun, 2020 | Amount | Post-IPO - Amyris | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Amyris
Amyris has secured backing from 19 investors, including venture fund and institutional investors. Prominent investors backing the company include SAS, Kleiner Perkins and dsm-firmenich. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location | |
|
Capital is provided to support biomedical industry innovations.
|
Founded Year | Domain | Location | |
|
Venture capital and private equity firm
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Amyris
Amyris has strategically engaged in corporate development activities, having acquired 8 companies. Notable acquisitions include Beauty Labs, Costa Brazil and Draths Corporation. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Probiotic supplements for menopause symptoms are developed.
|
2019 | ||||
|
Natural skincare products are offered through an internet-first brand.
|
2017 | ||||
|
Influencer marketing, content marketing, and branding services are provided.
|
2017 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Amyris
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Amyris Comparisons
Competitors of Amyris
Amyris operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Syngenta, AskBio, Ginkgo Bioworks, Twist Bioscience and Antheia, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Crop protection solutions and hybrid seeds are provided for farming.
|
|
| domain | founded_year | HQ Location |
Gene and protein therapies are developed for treating various diseases.
|
|
| domain | founded_year | HQ Location |
Gene editing-based cultured ingredients are provided for agriculture.
|
|
| domain | founded_year | HQ Location |
Synthetic DNA is synthesized via a semiconductor-based platform.
|
|
| domain | founded_year | HQ Location |
Yeast cells are genetically engineered to produce medicinal products.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Amyris
Frequently Asked Questions about Amyris
When was Amyris founded?
Amyris was founded in 2003 and raised its 1st funding round 2 years after it was founded.
Where is Amyris located?
Amyris is headquartered in Emeryville, United States. It is registered at Emeryville, California, United States.
Is Amyris a funded company?
Amyris is a funded company, having raised a total of $487.2M across 61 funding rounds to date. The company's 1st funding round was a Post-IPO of $200M, raised on Jun 01, 2005.
How many employees does Amyris have?
As of Dec 31, 2022, the latest employee count at Amyris is 747.
What is the annual revenue of Amyris?
Annual revenue of Amyris is $269.85M as on Dec 31, 2022.
What does Amyris do?
Amyris was founded in 2003 and is headquartered in Emeryville, United States. Renewable products are developed for various industrial applications, with a focus on consumer materials, polymers, biofuels, and lubricants. Efforts are also directed toward semi-synthetic artemisinin as a treatment for malaria. Operations center on biotechnology and sustainable chemistry within the renewables sector.
Who are the top competitors of Amyris?
What products or services does Amyris offer?
Amyris offers Sustainable Ingredients and Squalene.
How many acquisitions has Amyris made?
Amyris has made 8 acquisitions, including Beauty Labs, Costa Brazil, and Draths Corporation.
Who are Amyris's investors?
Amyris has 19 investors. Key investors include SAS, Kleiner Perkins, dsm-firmenich, Khosla Ventures, and TPG.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.